34 References

Borody, Thomas J., and Alexander Khoruts. “Fecal Microbiota Transplantation and Emerging Applications.” Nature Reviews. Gastroenterology & Hepatology, vol. 9, no. 2, Dec. 2011, pp. 88–96.

Brandt, Lawrence J., et al. “Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection.” The American Journal of Gastroenterology, vol. 107, no. 7, July 2012, pp. 1079–87.

Sbahi, Hani, and Jack A. Di Palma. “Faecal Microbiota Transplantation: Applications and Limitations in Treating Gastrointestinal Disorders.” BMJ Open Gastroenterology, vol. 3, no. 1, May 2016.

Suskind, David L., et al. “Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn’s Disease.” Inflammatory Bowel Diseases, vol. 21, no. 3, Mar. 2015, pp. 556–63.

Zhang, Fa-Ming, et al. “Fecal Microbiota Transplantation for Severe Enterocolonic Fistulizing Crohn’s Disease.” World Journal of Gastroenterology : WJG, vol. 19, no. 41, Nov. 2013, pp. 7213–16.

Zhang, Faming, et al. “Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?” The American Journal of Gastroenterology, vol. 107, no. 11, Nov. 2012, p. 1755.

He Zhi, Li Pan, Zhu Jianguo, Cui Bota, Xu Lijuan, Xiang Jie, Zhang Ting, Long Chuyan, Huang Guangming, Ji Guozhou, NieYongzhan, Wu Kaichun, Fan Daiming & Zhang Faming. “Multiple fresh fecal microbiota transplants induces and maintains clinical remission in crohn’s disease complicated with inflammatory mass” Scientific Reports, vol. 7, no. 1, 2017, p. 4753.

Zymo Research. Setting Standards for Reproducibility in Gut Microbiome Research. Nat Genet.  2018;50(10)

Feagins, L. A., Holubar, S. D., Kane, S. V. & Spechler, S. J. Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 9. 2011, 842–850 .

Lichtenstein, G. R., Hanauer, S. B. & Sandborn, W. J. Management of Crohn’s disease in adults. The American journal of gastroenterology. 2009,104, 465–483.

Baumgart, D. and Carding, S. Inflammatory bowel disease: cause and immunobiology. The Lancet. 2007, 369(9573), pp.1627-1640.

Crohn’s Disease – Causes and Symptoms. Mayo Clinic. March 8, 2018. https://www.mayoclinic.org/diseases-conditions/crohns-disease/symptoms-causes/syc-20353304

Impact of IBD in Canada. Crohn’s and Colitis Canada. 2018. http://crohnsandcolitis.ca/About-Us/Resources-Publications/Impact-of-IBD-Report

Figure 1 a,b: “About Crohn’s & Colitis.” Crohn’s & Colitis Australia, www.crohnsandcolitis.com.au/about-crohns-colitis/.

Hanley, Matt. “Muscosal Healing: A New Paradigm in IBD Treatment.” Muscosal Healing: A New Paradigm in IBD Treatment, Thetis Pharmaceuticals, February 6/2018, http://thetispharma.com/cms2/mucosal-healing-new-paradigm-ibd-treatment/.

 

License

Selected Topics in Health and Disease Copyright © by Bill Ju and pfrench. All Rights Reserved.

Share This Book